LTT Bio-Pharma And GaleniSearch Laboratories Conclude Licensing Agreement For Hydroxyapatite Sustained-Release Particle Formula

Tokyo (JCNN) - LTT Bio-Pharma has announced that it has signed a licensing agreement with GaleniSearch Laboratories, a venture company engaged in drug delivery system (DDS) development and established by the Japan Science and Technology Agency and the St. Marianna University School of Medicine.

MORE ON THIS TOPIC